Stay updated with breaking news from Resolution Bioscience Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Metagenomics Market Size, Share & Trends Analysis Report by Technology (Shotgun Sequencing, 16S Sequencing), by Product, by Workflow, by...
/PRNewswire/ -- According to Coherent Market Insights, the global polymerase chain reaction market is estimated to be valued at US$ 5,627.9 million in 2022 and...
/PRNewswire/ -- The global NGS sample preparation market was worth around $1,598.8 million in 2021, and it is expected to reach $5,501.2 million by 2030,...
Share this article Share this article ResearchAndMarkets.com's offering. The scope of the report includes liquid biopsy technologies, applications, industry subsegments, biomarker technologies, major funding initiatives, patents and companies. The market sizes for liquid biopsy diagnostics are given for 2019, 2020 and 2025 (forecasted). Liquid biopsy is creating a paradigm shift in medicine, and this is opening significant market opportunities. These market segments are particularly promising for the following liquid biopsy applications: noninvasive prenatal screening for average-risk populat...
Agilent to acquire Resolution Bioscience for $695 M Agilent to acquire Resolution Bioscience for $695 M 03 March 2021 | News Source credit: Shutterstock Agilent Technologies Inc has announced that it has entered into a definitive agreement to acquire Resolution Bioscience Inc, a leader in the development and commercialisation of next-generation sequencing (NGS)-based precision oncology solutions. The acquisition complements and expands Agilent’s capabilities in NGS-based cancer diagnostics and provides the company with innovative technology to further serve the needs of the fast-growing pr...